The Relentless Progression of Metabolic Dysfunction–associated Steatotic Liver Disease in Liver Transplantation in Spain

The burden of MASLD-related LT in Spain is growing, yet at a less pronounced rate than in the United States/Canada. Whether this slower increase will persist or decline in the future as newer antiobesity and MASLD-related drugs are increasingly used is still unknown. In the meantime, our results highlight the need for tailored approaches to management and prevention in the Spanish population and underscore the importance of continued monitoring and research into the evolving impact of MASLD on LT in Spain and beyond.

Authors

Institutions

Publication Details

Journal
Transplantation
Published
2025-10-31
DOI
https://doi.org/10.1097/tp.0000000000005554
Primary Topic
Liver Disease Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

The Relentless Progression of Metabolic Dysfunction–associated Steatotic Liver Disease in Liver Transplantation in Spain

J.I. Herrero, Mohammad Shadab Siddiqui, Ângela Carvalho‐Gomes, Fernando Díaz‐Fontenla et al.
Transplantation
Liver Disease Diagnosis and Treatment
article

The Relentless Progression of Metabolic Dysfunction–associated Steatotic Liver Disease in Liver Transplantation in Spain

J.I. Herrero, Mohammad Shadab Siddiqui, Ângela Carvalho‐Gomes, Fernando Díaz‐Fontenla, Nazia Selzner, Danielle Brandman, Sanjaya K. Satapathy, Kymberly D. Watt, Laura Martínez‐Arenas, Sara Lorente, Marta Guerrero-Misas, Saleh Elwir, Enrique Vidal, Coleman I. Smith, Marina Berenguer, Mary E. Rinella
article en

Abstract

The burden of MASLD-related LT in Spain is growing, yet at a less pronounced rate than in the United States/Canada. Whether this slower increase will persist or decline in the future as newer antiobesity and MASLD-related drugs are increasingly used is still unknown. In the meantime, our results highlight the need for tailored approaches to management and prevention in the Spanish population and underscore the importance of continued monitoring and research into the evolving impact of MASLD on LT in Spain and beyond.

TransplantationVol. 110(2)
Northwestern University (US), University of California, San Francisco (US), Georgetown University (US), Virginia Commonwealth University (US), University of Toronto (CA), Instituto de Salud Carlos III (ES), Baylor University Medical Center (US), MedStar Georgetown University Hospital (US), Hospital General Universitario Gregorio Marañón (ES), Hospital Universitari i Politècnic La Fe (ES), Instituto Maimónides de Investigación Biomédica de Córdoba (ES), Hospital Universitario Reina Sofía (ES), Mayo Clinic in Arizona (US), Clinica Universidad de Navarra (ES), Hospital Clínico Universitario Lozano Blesa (ES), Instituto de Investigación Sanitaria Aragón (ES), Methodist University Hospital (US), Instituto de Investigación Sanitaria La Fe (ES), Universitat Politècnica de València (ES), Universidad de Navarra (ES)
Openalex Percentile: Top 58%
Liver Disease Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.